Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential drug-drug interactions between
ofatumumab and bendamustine in subjects with previously untreated or relapsed indolent B-cell
non-Hodgkin's lymphoma (NHL).